FDA Drug/Biologics Approval BLA 125514 S-097, PEMBROLIZUMAB

FDA Drug/Biologics Approval BLA 125514 S-097, PEMBROLIZUMAB

Regular price $149.00 USD
Regular price Sale price $149.00 USD
Sale Sold out
BLA 125514 S-097
Company: MERCK SHARP DOHME
Drug Name: KEYTRUDA
Active Ingredients: PEMBROLIZUMAB
Strength: 100MG/4ML (25MG/ML)
Dosage Form/Route: SOLUTION;INTRAVENOUS
Action Date: 09/04/2014
Marketing Status: Prescription
Submission Classification: ORIG-1

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details